{
    "SPADE_UN_18758": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18758",
            "Peptide Name": "CFPS_AMP_3 (cell-free protein synthesis-AMP 3, AI predicted AMPs, Lys-rich; UCLL1)",
            "Source": "AI predicted, machine learning prediction of known protein sequences",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "MNNRGPLGRRFKARRKWKKFVAGKMKKKRKRFKGFKKKGGFTPFVKKFV",
            "Sequence Length": 49,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 5931.27,
            "PI": 12.0,
            "Hydrophobicity": -1.24,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Pandi A, Adam D, Zare A, Trinh VT, Schaefer SL, Burt M, Klabunde B, Bobkova E, Kushwaha M, Foroughijabbari Y, Braun P, Spahn C, Preußer C, Pogge von Strandmann E, Bode HB, von Buttlar H, Bertrams W, Jung AL, Abendroth F, Schmeck B, Hummer G, Vázquez O, Erb TJ. 2023",
                    "Reference": "Nat Commun. 2023 Nov 8;14(1):7197. doi: 10.1038/s41467-023-42434-9.PubMed",
                    "Title": "Cell-free biosynthesis combined with deep learning accelerates de novo-development of antimicrobial peptides."
                }
            ],
            "Frequent Amino Acids": "KFR",
            "Absent Amino Acids": "CDEHIOQSUY",
            "Basic Residues": 22,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 18,
            "Polar Residues": 30,
            "Positive Residues": 22,
            "Negative Residues": 0,
            "Net Charge": 22,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is most similar (37.04%) toNA-CATH. K: 31%; F=R: 14%; G: 12%.Activity: active against E. coli (MIC 12.5 uM), B. subtilis (MIC 0.8 uM), A. baumannii clinical strain (MIC 6.3 uM), Enterobacter spp. (MIC >25 uM), K-pneumoniae DSM 30104 (MIC>25 uM), P. aeruginosa DSM 1117 (MIC 9.4 uM), S. aureus DSM 11729 MRSA (MIC 12.5 uM), E. faecium (MIC 1.6 uM), Y. pestis EV76 (MIC 12.5 uM), B. anthracis Sterne (MIC 12.5 uM), and S-pneumoniae D39 (MIC > 25 uM).Toxicity: Human RBC: HC50>250 uM, not hemo.lytic.Resistance development:no:bacteria:E. coli: E. coli did not develop resistance to the peptide after 21 passages. In contrast, the MIC of imipenem increased by 8 fold.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_01191",
                    "Similarity": 0.7333333333333333,
                    "Sequence": "KFKKFKKFKKFKKFK"
                },
                {
                    "SPADE_ID": "SPADE_UN_11215",
                    "Similarity": 0.7142857142857143,
                    "Sequence": "KKKKKKK"
                },
                {
                    "SPADE_ID": "SPADE_UN_17724",
                    "Similarity": 0.7,
                    "Sequence": "CWKKKKKKKK"
                }
            ]
        }
    }
}